ReviewLeukemia & lymphoma2022

T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscape.

Dickran Kazandjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.